Rationale and design of the regimen education and messaging in diabetes (REMinD) trial.
O'Conor R, Arvanitis M, Wismer G, Opsasnick L, Sanchez Muñoz A, Kannry J, Lin JJ, Kaiser D, Kwasny MJ, Persell SD, Parker R, Wood AJJ, Federman AD, Wolf MS.
O'Conor R, et al. Among authors: arvanitis m.
Contemp Clin Trials. 2019 Aug;83:46-52. doi: 10.1016/j.cct.2019.06.016. Epub 2019 Jun 28.
Contemp Clin Trials. 2019.
PMID: 31260791
Free PMC article.